Edition:
United Kingdom

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

2.40USD
4:13pm BST
Change (% chg)

$0.05 (+2.13%)
Prev Close
$2.35
Open
$2.35
Day's High
$2.40
Day's Low
$2.35
Volume
384
Avg. Vol
9,434
52-wk High
$2.85
52-wk Low
$1.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.315
Sep '17 0.00 -1.084
Jun '17 0.00 -0.326
Mar '17 0.00 -0.391
FY 2016 Dec '16 0.00 -0.420
Sep '16 0.00 -0.429
Jun '16 0.00 -0.477
Mar '16 0.00 -0.397
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 4 16.58 63.80 0.00 10.12
Earnings (per share)
Quarter Ending Jun-18 5 -0.35 -0.29 -0.48 -0.34
Quarter Ending Sep-18 5 -0.36 -0.29 -0.49 -0.37
Year Ending Dec-18 5 -1.42 -1.18 -1.92 -1.36
Year Ending Dec-19 5 -1.28 -0.75 -1.48 -0.91
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.91 33.50
P/E High - Last 5 Yrs. -- 289.20 46.07
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta 1.48 0.75 0.80
Price to Sales (TTM) -- 139.09 7.25
Price to Book (MRQ) 3.14 20.64 5.09
Price to Tangible Book (MRQ) 1.20 25.50 6.62
Price to Cash Flow (TTM) -- 130.26 25.50
% Owned Institutions 74.92 11.26 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.05 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 81.71 8.68
Sales (TTM) vs TTM 1 Yr. Ago -- 96.34 11.19
Sales - 5 Yr. Growth Rate -- 34.26 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 24.92 -64.57 22.73
EPS (TTM) vs TTM 1 Yr. Ago -22.84 -- --
EPS - 5 Yr. Growth Rate -- 48.47 10.28
Capital Spending - 5 Yr. Growth Rate -12.18 45.82 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.53
Current Ratio (MRQ) 4.71 6.04 3.61
LT Debt to Equity (MRQ) 0.00 23.33 11.39
Total Debt to Equity (MRQ) 0.00 25.72 14.02
Interest Coverage (TTM) -- -190.60 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 35.01 54.05
Gross Margin - 5 Yr. Avg. -- 55.51 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -3,197.22 -150.51 15.90
Operating Margin (TTM) -- -562.45 4.09
Operating Margin - 5 Yr. Avg. -3,210.28 -162.33 11.23
Pre-Tax Margin (TTM) -- -534.74 4.81
Pre-Tax Margin - 5 Yr. Avg. -3,090.94 -168.92 11.54
Net Profit Margin (TTM) -- -524.03 1.42
Net Profit Margin - 5 Yr. Avg. -3,090.94 -168.92 7.87
Effective Tax Rate (TTM) -- -0.15 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.29 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,331,705 813,295,447
Net Income/Employee (TTM) -- 1,121,504 95,590,786
Receivable Turnover (TTM) -- 6.53 5.56
Inventory Turnover (TTM) -- 2.32 3.44
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -68.49 -0.74 10.51
Return on Assets - 5 Yr. Avg. -40.07 0.80 11.54
Return on Investment (TTM) -81.89 -0.75 13.17
Return on Investment - 5 Yr. Avg. -45.37 4.16 14.94
Return on Equity (TTM) -142.13 -2.86 14.98
Return on Equity - 5 Yr. Avg. -234.41 -0.19 16.23
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.38 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteon Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.92%
# of Holders: 35
Total Shares Held: 13,242,127
3 Mo. Net Change: 29
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.